Smartwatch AI may predict liver crisis before symptoms start
NCT ID NCT07721454
First seen Jul 23, 2026 · Last updated Jul 24, 2026 · Updated 1 time
Summary
This study tests whether an Apple Watch, combined with artificial intelligence, can detect early signs of improvement or deterioration in people with advanced chronic liver disease (cirrhosis). Participants wear the watch to continuously track heart rate, oxygen levels, sleep, activity, and other health signals. The goal is to see if these data patterns can predict a patient's clinical course and ultimately help guide care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Apple Watch (wearable device) paired with artificial-intelligence analysis
- What this could lead to
- If it works, this could point toward a non-invasive way to catch early signs of liver-disease worsening, potentially improving care and quality of life.
- What could go wrong
- This is a very small, early feasibility study with only 8 participants. The AI analysis may not prove accurate or generalizable, and wearing a smartwatch may not be practical for all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCE CHRONIC LIVER DISEASE (ACLD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ente Ospedaliero Cantonale
Lugano, 6900, Switzerland